Back to Studies

P1017 / PEG-Intron in HIV+Children

Safety, Tolerability, and Antiviral Pharmacodynamics of PEG-Intron in HIV-1 Infected Children

Study Status

Concluded

DAIDS Number

10317

IND Number

BB9197

Study Chair

Study Vice-Chair

CCG Representative

Clinical Research Manager

DAIDS Clinical Representative

Data Manager

Drug Co. Representative

Field Representative

Immunologist

Laboratory Technologist

Medical Officer

Neuropsychologist

Pharmacologist

Senior Statistician

Statistician

Virologist